Skinfold thickness, local subcutaneous blood flow and insulin absorption in diabetic patients. 1991

P Hildebrandt
Department of Cardiology, Gentofte Hospital, University of Copenhagen, Denmark.

The influence of skinfold thickness on the local subcutaneous blood flow (SBF) and absorption rate of subcutaneously injected and infused soluble insulin was investigated in insulin-dependent diabetic patients. The local 133Xenon washout technique was used for measuring SBF and the disappearance of 125I labelled insulin for measuring insulin absorption. A Harpenden skinfold caliper was used for measuring skinfold thickness. A large variation in skinfold thickness (range 6-40 mm, N = 50) was demonstrated. The SBF was curvilinear related to the skinfold thickness with decreasing SBF for increasing skinfold thickness (N = 50). A similar relationship was found between the SBF and the absorption rate of subcutaneously injected (N = 10) and infused (N = 7) insulin. The large variation in skinfold thickness and thus insulin absorption may partly explain the well-known large inter-individual variation in insulin absorption, and the different absorption rates from areas with different skinfold thickness should be taken into account when treating with insulin.

UI MeSH Term Description Entries
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001783 Blood Flow Velocity A value equal to the total volume flow divided by the cross-sectional area of the vascular bed. Blood Flow Velocities,Flow Velocities, Blood,Flow Velocity, Blood,Velocities, Blood Flow,Velocity, Blood Flow
D003238 Connective Tissue Tissue that supports and binds other tissues. It consists of CONNECTIVE TISSUE CELLS embedded in a large amount of EXTRACELLULAR MATRIX. Connective Tissues,Tissue, Connective,Tissues, Connective
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000042 Absorption The physical or physiological processes by which substances, tissue, cells, etc. take up or take in other substances or energy.

Related Publications

P Hildebrandt
September 1988, The Journal of clinical endocrinology and metabolism,
P Hildebrandt
July 1984, Diabetic medicine : a journal of the British Diabetic Association,
P Hildebrandt
April 1987, Diabetes research (Edinburgh, Scotland),
P Hildebrandt
January 1962, The American journal of the medical sciences,
P Hildebrandt
April 1991, Lancet (London, England),
Copied contents to your clipboard!